BUDESONIDE 80mcg/FORMOTEROL 4.5 mcg/p, 120 puffs, inhaler
Valid Article
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
BUDESONIDE / FORMOTEROL inhaler
Therapeutic Action
Combination of inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) inhaled bronchodilator:
- Budesonide: a glucocorticoid with anti-inflammatory effects in the lungs, resulting in reduced asthma symptoms and exacerbations, with less adverse effects compared to systemic corticosteroids.
- Formoterol: a selective beta2-adrenergic agonist that produces relaxation of bronchial smooth muscle in patients with reversible airways obstruction. Its bronchodilation effect begins rapidly, within 1-3 minutes after inhalation, and lasts for up 12 hours after a single dose.
Indications
Treatment of moderate to severe persistent asthma in children
Instructions for use
The combination of budesonide and formoterol is available in two forms for inhalation:
- Pressurised Metered-Dose Inhaler (MDI): a device equipped with a small canister containing a mixture of the medicine and a pressurised propellant. The pressure from the propellant delivers the medicine when the canister is pushed down into the boot/actuator.
- Dry-Powder Inhaler (DPI): a breath-actuated device that delivers the medicine as a fine, dry powder often pre-loaded in a capsule or blister within the device and punctured by the device prior to use.
Manufacturers may express the content per puff as either:
- in metered dose: the quantity of medicine in the device metering chamber, excluding the valve
- in delivered dose: (the quantity of medicine delivered to the user, excluding the mouthpiece.
- Always refer to the product leaflet.
Budesonide/Formoterol inhalers generally supplied by MSF are Dry-Powder Inhalers (DPI). Refer to the information leaflet for appropriate instructions for use, according to the inhaler model.
Precautions for Use
Do not use for the treatment of an acute asthma attack.
In children, use an inhalation chamber/spacer with or without a mask (depending on the child's age) for every administration of a pressurised metered-dose inhaler.
Only use the mouthpiece supplied with the inhaler. Do not substitute it with any other mouthpiece.
Transport Dangerous Goods
UN transport code (for Pressurised Metered-Dose Inhaler - MDI):
- UN 1950 - Aerosols, non-flammable (each not exceeding 1 L capacity)
- Transport Class 2.2 - Non-flammable, non-toxic gases
- Transport is only regulated for large quantities of aerosols.
Storage
- Below 25ºC
- Used pressurised inhaler: do not pierce or incinerate. Empty any residual gas before disposal. Dispose of by burying.
- The pressurised metered-dose inhalers are CFC free. Chlorofluorocarbons (CFCs) are harmful to the ozone layer. Instead, these inhalers use HFA (hydrofluoroalkane) propellants, which are a more effective and environmentally friendly alternative.
![[EMEQSPAC2--] SPACER, 155 ml, + silicone masks size1 & size2 + mouthpiece](/web/image/product.template/572883/image_256/%5BEMEQSPAC2--%5D%20SPACER%2C%20155%20ml%2C%20%2B%20silicone%20masks%20size1%20%26%20size2%20%2B%20mouthpiece?unique=ebcb97f)
![[SMSUSPAC4M-] SPACER, single patient, medium mask](/web/image/product.template/569846/image_256/%5BSMSUSPAC4M-%5D%20SPACER%2C%20single%20patient%2C%20medium%20mask?unique=2703dc8)
![[SMSUSPAC4S-] SPACER, single patient, small mask](/web/image/product.template/569849/image_256/%5BSMSUSPAC4S-%5D%20SPACER%2C%20single%20patient%2C%20small%20mask?unique=b0ae972)